Genetic Pathways and Peptide Response: A Precision Lens Recent research highlights genetic variants in GLP-1 receptor (GLP1R), glucose-dependent insulinotropic peptide receptor (GIPR), fat mass and obesity associated gene (FTO), and melanocortin-4 receptor (MC4R) that may correlate with baseline BMI, weight-loss trajectory, and side-effect tolerability
Most patients notice the first mild nausea 2448 hours after injection, with peak symptoms arriving around day 35
Um, and if we could, again, intervene early before these people are on, on the decline, but it definitely shows in studies to slow the progression of Alzheimer's, which is pretty fascinating
doi: 10.1016/S1474-4422(22)00188-0, 39
3B) was detected in the brainstem at 60 min post-injection, specifically in Y1-R and/or GLP-1R-expressing cells within the AP and the NTS